CLSN - セルシオン （Celsion Corporation）

Celsion (CLSN) announced Monday its decision to change company''s name to Imunon. The new name of clinical-stage drug development company is claimed to outline the "evolution of its…

According to Benzinga Pro data, during Q2, Celsion (NASDAQ: CLSN ) posted sales of $125 thousand. Earnings were up 42.31%, but Celsion still reported an overall loss of $6.04 million. Celsion collected $125 thousand in revenue during Q1, but reported earnings showed a $10.47 million loss. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and … Full story available on Benzinga.com

LAWRENCEVILLE, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN ), a clinical-stage drug development company today announced that Dr. Corinne Le Goff, President and Chief Executive Officer will present a company overview and be available for 1x1 meetings at the upcoming H.C. Wainwright 24 th Annual Global Investment Conference. The hybrid conference will be held from September 12-14 with in-person participation held at the Lotte New York Palace Hotel.

Celsion (CLSN) said on Thursday that additional data from its completed proof-of-concept mouse challenge study confirmed that its DNA-based placcine vaccine can produce robust levels…

Celsion Corporation (NASDAQ:NASDAQ:CLSN) Q2 2022 Earnings Conference Call August 15, 2022, 11:00 am ET Company Participants Monique Kosse - IR, LifeSci Advisors Michael Tardugno - Executive…

Clinical-stage biotech Celsion Corporation (CLSN) announced on Tuesday that the company appointed Corinne Le Goff as its President and Chief Executive Officer effective July 18, 2022

Celsion Corporation (NASDAQ:NASDAQ:CLSN) Q1 2022 Earnings Conference Call May 16, 2022 11:00 ET Company Participants Monique Kosse - Investor Relations Michael Tardugno - Chairman, Chief…

Celsion (NASDAQ: CLSN ) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings Celsion missed estimated earnings by 83.84%, reporting an EPS … Full story available on Benzinga.com

Celsion press release (CLSN): Q1 GAAP EPS of -$1.82 misses by $0.82.Revenue of $0.13M (flat Y/Y) beats by $0.02M.The Company had $47.3 million in cash, investments and restricted…

DNA Mediated Immunotherapy and Next-Generation Vaccine Programs Supported with a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT

Celsion Corp (CLSN) shares closed 1.4% lower than its previous 52 week low, giving the company a market cap of $54M. The stock is currently down 12.2% year-to-date, down 15.1% over the past 12 months, and down 87.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.6%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 28.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -47.4% The company's stock price performance over the past 12 months beats the peer average by -47.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

AT&T Inc. (NYSE:T) with the stream of 0.36% also noticed, India Celsion Corporation (NASDAQ:CLSN) encountered a rapid change of -2.62% in the last hour of Thursdays trading session. AT&T Inc. The post Investors Alert (ATR Analysis): AT&T Inc. (NYSE:T), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .

Sundial Growers Inc. (NASDAQ:SNDL) with the stream of -0.37% also noticed, India Celsion Corporation (NASDAQ:CLSN) encountered a rapid change of 2.87% in the last hour of Wednesdays trading session. Sundial The post Hair-raising Facts to Know: Sundial Growers Inc. (NASDAQ:SNDL), Celsion Corporation (NASDAQ:CLSN) appeared first on Stocks Equity .

State Street Corp bought a new position in shares of Celsion Co. (NASDAQ:CLSN) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 214,568 shares of the biotechnology companys stock, valued at approximately $273,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the []